Skip to main content
Back to IMM Investment

IMM Investment's Biopharma Portfolio

Browse 8 Biopharma companies funded by IMM Investment. See funding amounts, founder contacts, and investment details.

Biopharma Companies
8
Total Funding in Biopharma
$195.6M

Biopharma Portfolio Companies (8)

Export
BiopharmaBiotechnologyPharmaceutical

Trioar is a biotechnological research company that manufacture pharmaceutical products and drugs.

Daejeon, South Korea
July 2025
$16.2M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics

Illimis Therapeutics is a science and technology company that develops treatment for degenerative brain and autoimmune diseases.

Seoul, South Korea
July 2025
$41.9M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Kobiolabs is a microbiome-based venture

Seongnam, South Korea
March 2022
$8.3M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Selecxine is a biopharmaceutical development company specialized in the field of immunotherapeutics.

Songpadong, South Korea
March 2022
$27.3M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalTherapeutics

BIORCHESTRA creates novel RNA-based therapeutics that will usher in a new era of treatment for neurodegenerative diseases.

Yusong, South Korea
February 2022
$45.7M
Series C

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnology

Curocell’s OVIS™ technology enhances immune cells to overcome immune suppression in tumor microenvironments.

Daejeon, South Korea
January 2022
$30.1M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

J2H Biotech is a bio-venture company focusing on the development of small-molecule drugs for the treatment of intractable rare diseases.

Seongnam, South Korea
July 2021
$26.2M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyMedical

EuBiologics provides and develops biopharmaceutical products.

Seoul, South Korea
October 2018
Series Unknown

Founder Contacts

41,000+ verified contacts

Explore IMM Investment's Full Portfolio

View all companies funded by IMM Investment across every industry and funding stage.

View Full IMM Investment Portfolio